Year: 2025

Eli Lilly and NVIDIA Announce Partnership to Build Advanced AI Supercomputer

Pharmaceutical giant Eli Lilly and technology firm NVIDIA have disclosed a collaboration to construct a new supercomputing system. The project…

Read More »

Landmark Trade Agreement Shapes UK-US Pharmaceutical Market

The United Kingdom and the United States have reached a bilateral agreement to maintain zero tariffs on UK pharmaceutical shipments…

Read More »

Noble Gesture Revives 16 Lives in 48 Hours

In just one weekend (November 29 – November 30), a profound humanitarian gesture of organ donation from three brain-dead individuals,…

Read More »

High-Level Personnel Appointment Bolsters Health Trade Union Activities

On December 1, the Vietnam General Confederation of Labour (VGCL) announced a significant personnel decision, appointing Mr. Nguyen Luong Tam,…

Read More »

Strategic Direction Towards Universal Free Healthcare Unveiled

On the afternoon of December 1, the Ministry of Health (MoH) organized a workshop to gather expert opinions on the…

Read More »

Vietnam’s Ministry of Health Expands List of Diseases Under Surveillance

The Ministry of Health (MoH) has issued a Decision adding 12 diseases to the list of Group A and Group…

Read More »

International Scientific Collaboration Advances Infectious Disease Research

A Vietnamese Research Institute has collaborated with Stanford University’s Institute for Microbiology and Epidemiology (US) to implement international-standard Hepatitis D…

Read More »

Stress Management for Leaders: A Critical Competency in Modern Leadership

In today’s volatile business environment, leaders must think fast, stay resilient, and make high-stakes decisions with clarity. Stress is no…

Read More »

Hot Jobs Of The Week 01 – 07.12.2025

Read More »

Stroke: Pathophysiology – Epidemiology – Emergency Management & Prevention

Abstract Stroke, including ischemic and hemorrhagic types, remains the second leading cause of death and a major cause of long-term…

Read More »

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval

The U.S. Food and Drug Administration (USFDA) has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of adults…

Read More »

Generic Drug Approval Secured for Type 2 Diabetes Treatment in the US

A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for…

Read More »

Major Pharmaceutical Group Acquires Preclinical Cancer Asset

In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach…

Read More »

Novel Immunotherapy Regimen Approved for Early-Stage Gastric Cancer

The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with…

Read More »

Expedited Review Sought for New Higher-Dose Obesity Treatment

A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food…

Read More »

Global Strategic Restructuring: A Major Pharma Group’s Shift Toward Automation and Production Reallocation

The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing…

Read More »

Cost-Effective Solution for Retinal Diseases Enters European Market

On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).…

Read More »

Investigating Antibiotic Strategies to Address a Global Health Challenge

Antimicrobial Resistance (AMR) is emerging as a critical worldwide public health threat, with the potential to cause at least 10…

Read More »

HCMC University Medical Centre and Novartis Strengthen Medical Collaboration

On November 19, in Ho Chi Minh City, the University Medical Centre of Hồ Chí Minh City (UMC) and Novartis…

Read More »